SONAR: Study of Diabetic Nephropathy with Atrasentan. A Randomized, Multi-country, Multi-center, Double-blind, Parallel, Placebo-controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy.
Aijaz Gundroo, MD Principal Investigator Rocco C. Venuto, MD Sub-investigator
Twelve faculty members with varied research and clinical expertise — representing four medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.
BUFFALO, N.Y. — University at Buffalo researchers have received a five-year, $3 million grant from the Troup Fund of the Kaleida Health Foundation to apply the power of big data to enhance liver health in the region.